NCT05507671View on ClinicalTrials.gov

The Role of BCG Vaccine in the Clinical Evolution of COVID-19 and in the Efficacy of Anti-SARS-CoV-2 Vaccines

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

556

Participants

Timeline

Start Date

May 27, 2021

Primary Completion Date

July 31, 2023

Study Completion Date

December 31, 2025

Conditions
COVID-19
Interventions
BIOLOGICAL

BCG (Bacillus Calmette-Guérin) vaccine

Application of BCG vaccine (0.1 ml intradermal) in the right arm deltoid insertion

OTHER

Placebo

Application of BCG solvent (0.1 ml intradermal) in the right arm deltoid insertion

Trial Locations (4)

69010-030

Policlínica Cardoso Fontes, Manaus

36036-900

Universidade Federal de Juiz de Fora, Juiz de Fora

66613-903

Centro Universitário do Pará, Belém

21040-360

Oswaldo Cruz Foundation, Rio de Janeiro

All Listed Sponsors
collaborator

University of Sao Paulo

OTHER

collaborator

Federal University of Juiz de Fora

OTHER

lead

Oswaldo Cruz Foundation

OTHER